B · Normal
[BofA Securities: Lowered the target price of Ali Health to HK$4.2 and reiterated the "buy" rating] On September 21, Bank of America Securities issued a research report stating that it lowered the target price of Ali Health from HK$5.1 to HK$4.2 and reiterated the "buy" rating. The bank lowered the company's fiscal 2027 revenue and adjusted net profit forecasts by 4% respectively, to a year-on-year increase of 9% to 37.4 billion yuan and a year-on-year decrease of 10% to 2.1 billion yuan, mainly affected by reduced platform subsidies and weaker non-pharmaceutical category sales.
Comments